Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Transcranial sonography of subcortical structures in patients with multiple sclerosis.
[Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in Asturias and Cantabria].
Risk of venous thromboembolism in neuromyelitis optica patients hospitalized for acute relapse.
Pain, cognition and quality of life associate with structural measures of brain volume loss in multiple sclerosis.
Response on Paraparetic Guillain-Barré syndrome: non-demyelinating reversible conduction failure restricted to the lower limbs.
Vitamin D modulates different IL-17-secreting T cell subsets in multiple sclerosis patients.
Inducible gene modification in the gastric epithelium of Tff1-CreERT2, Tff2-rtTA, Tff3-luc mice.
Characterization of mouse spinal cord vascular network by means of synchrotron radiation X-ray phase contrast tomography.
A Proteogenomic Approach to Understanding MYC Function in Metastatic Medulloblastoma Tumors.
WAIS-IV GAI and CPI discrepancies in multiple sclerosis and traumatic brain injury.
Mass Spectrometry-Based Quantitative Strategies for Assessing the Biological Consequences and Repair of DNA Adducts.
Antigen dynamics govern the induction of CD4(+) T cell tolerance during autoimmunity.
From Natural Product to the First Oral Treatment for Multiple Sclerosis: The Discovery of FTY720 (Gilenya™)?
YAP and TAZ control peripheral myelination and the expression of laminin receptors in Schwann cells.
Simulations on the influence of myelin water in diffusion-weighted imaging.
Cortical Volume Loss and Neurologic Dysfunction in Multiple Sclerosis.
Ultrasound pattern sum score, homogeneity score and regional nerve enlargement index for differentiation of demyelinating inflammatory and hereditary neuropathies.
Programmed cell death and natural killer cells in multiple sclerosis: new potential therapeutic targets?
New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies.
Regulating Axonal Responses to Injury: The Intersection between Signaling Pathways Involved in Axon Myelination and The Inhibition of Axon Regeneration.
Schwann cell differentiation inhibits interferon-gamma induction of expression of major histocompatibility complex class II and intercellular adhesion molecule-1.
Acute Disseminated Encephalomyelitis.
Survey of US Patients with Multiple Sclerosis: Comparison of the New Electronic Interferon Beta-1b Autoinjector (BETACONNECT™) With Mechanical Autoinjectors.
[Recurrent encephalitis following annual influenza vaccine. Case report].
Neuromuscular Determinants For Walking Performance In Individuals With Multiple Sclerosis: 2570 Board #93 June 3, 9: 30 AM - 11: 00 AM.

Pages